InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Alam Kamran, 首席财务官. Director active across 2 companies, notably Taysha Gene Therapies, Inc.. In total, 15 disclosures have been published. Split: 0 buy · 8 sells. Total volume traded: €829k. Activity tracked since 18 August 2021. The latest transaction was disclosed on 4 February 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Alam Kamran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
1,655 股@ US$4.524.5% 占其流量Common StockSEC:0001793412-26-000012:0
78,968 股@ US$4.7535.3% 占其流量Common StockSEC:0001793412-26-000008:0
23,849 股@ US$4.6110.3% 占其流量Common StockSEC:0001793412-26-000008:1
359,000 股0Common StockSEC:0001793412-26-000002:0
54,491 股@ US$2.85100.0% 占其流量Common StockSEC:0001415889-25-022749:0
29,843 股@ US$1.695.2% 占其流量Common StockSEC:0001415889-25-007997:0
431,000 股0Common StockSEC:0001415889-25-000595:0
1,288 股@ US$1.510.2% 占其流量Common StockSEC:0001415889-24-002809:0
590,413 股0Common StockSEC:0001209191-24-000811:0
33,000 股@ US$2.337.9% 占其流量Common StockSEC:0001209191-23-047323:0
6,230 股Common StockSEC:0001209191-23-033681:0
18,691 股Common StockSEC:0001209191-23-007396:0
3,325 股@ US$3.471.3% 占其流量Common StockSEC:0001209191-22-047353:0
7,476 股@ US$3.873.2% 占其流量Common StockSEC:0001209191-22-047097:0
11,193 股@ US$17.3522.5% 占其流量Common StockSEC:0001209191-21-052824:0
15 条申报中的 15 条
About Alam Kamran
Alam Kamran is Chief Financial Officer at Taysha Gene Therapies, Inc. He has 15 filings in total, and in the recent sample of 15 filings, the transactions are sales, totaling EUR 829265 between 2021-08-20 and 2026-02-06.
